APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN TREATING INFECTION ASSOCIATED WITH BURN OR SCALD INJURY

Pseudomonas aeruginosa Pseudomonas aeruginosa Pseudomonas aeruginosa Pseudomonas aeruginosa Pseudomonas aeruginosa Pseudomonas aeruginosa The present invention belongs to the field of microbiology, and particularly relates to an application of a vaccine in prevention and treatment of burn and scald...

Full description

Saved in:

Bibliographic Details
Format	Patent
Language	English
Published	21.08.2020
Online Access	Get full text

Cover

More Information
Summary:	Pseudomonas aeruginosa Pseudomonas aeruginosa Pseudomonas aeruginosa Pseudomonas aeruginosa Pseudomonas aeruginosa Pseudomonas aeruginosa The present invention belongs to the field of microbiology, and particularly relates to an application of a vaccine in prevention and treatment of burn and scald complicated with bacterial infection. The burn and scald of the present invention include burns and scalds, and degree of the scalds includes I degree, superficial II degree, deep II degree, or III degree scalds. Site of the scalds includes skin, mucosa or other tissues. The vaccine of the present invention can effectively prevent and treat burn and scald complicated with infection caused by multidrug-resistant by activating the specific immune response of the body. The vaccine of the present invention can reduce the bacterial load in the immunized subject through the established immunization procedures, thereby providing a technical solution that can effectively prevent burn and scald complicated with infection, which avoids the technical problems caused by the use of antibiotics such as poor effectiveness, difficulty in curing and proneness to drug resistance in the prior art to a certain degree.